June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

Long renowned for its rich history, striking architecture, and thriving technology sector, Prague – and Czechia as a whole – is increasingly gaining recognition for something else: a fast-growing life ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

Novartis’ current strategy can be traced back to October 2023, when the Swiss pharma completed the spin-off of Sandoz, its generics and biosimilars business. The company described the move as the ...

Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.

An unsustainable demand for meat has led to companies looking for alternative solutions to conventional farming methods in order to change the way we eat and think about meat. For biotech companies in ...

For people living with sickle cell disease, it means facing lifelong challenges marked by episodes of severe pain, fatigue, and frequent medical visits. This is because the inherited blood disorder, ...

California-based Cargo Therapeutics has had a rough year with its CAR-T cell therapy firicabtagene autoleucel being discontinued after patients experienced toxic side effects in the clinic. The ...

Psychedelic drugs have the potential to become an effective treatment for crippling mental health conditions such as depression. In this article, we take a look at six of the top psychedelic companies ...

Last year, we took a look at the biotech trends that we thought would shape 2024. Now, as we enter the new year, the biotech industry is continuing to evolve at a rapid pace, and 2025 is shaping up to ...